Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 1996

View Archived Issues

New antiviral agents from CNRS

New hypolipidemic agents claimed by Janssen

Positive GABAA receptor complex modulators claimed

Tyrosine kinase inhibitors described by Pharmacia & Upjohn

MMP/TNF inhibitors reported by Pfizer

New antidepressant compounds in development at HMR

Novel dual-action compounds described by Abbott

NOS inhibitors described by Searle

Italian researchers described novel anti-HIV compounds

Daiichi claims LTD4 antagonists for treating allergic diseases

Drugs quicker to reach market in U.S. than in Germany and Japan

EchoGen Emulsion initial trial results in prostate disease revealed

GastroMARK approved for marketing by FDA

hu1124 advances to clinical studies

Millennium/Lilly's gene-based assay for atherosclerosis

Janssen files for lower-dose risperidone in U.S.

Procept's topical microbicide enters phase I in Europe

Boehringer Mannheim markets HGV diagnostic developed under collaboration with Genelabs

Mitsubishi Chemical isolates novel antitumor agent from plant source

New antitumor agents from Kyowa Hakko

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

CEPRATE SC approved for marketing in U.S.

VISX supplemental PMA slated for review

Company Profile: Aurora Biosciences

Positive clinical results reported for MDX-22 in AML patients

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Positive clinical results for Targretin reported at ASH meeting

NAVA-Chiron Behring vaccine distribution agreement signed

Cellcor, Neoprobe sign RIGS/ACT manufacturing agreement

Oncor issued U.S. patent on technology for early detection of breast cancer

Biogen, Creative BioMolecules to codevelop drugs for renal disorders

First approval for Pharmacyclics' MRI contrast agent

Bristol-Myers Squibb and NIH continue Taxol collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...